SCHEMBL286156

SCHEMBL286156

Cc1onc(-c2ccccn2)c1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
TSHR P16473 1/20 0.45
GABRA5 P31644 5/20 0.44
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 3/20 0.42
PKM P14618 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GAA P10253 2/20 0.42
MITF O75030 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
EDNRA P25101 2/20 0.41
TP53 P04637 2/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
METAP1 P53582 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24656022 0.78 NPC1 (0.49) ALDH1A1TSHRGABRA5NPC1KDM4E
SCHEMBL195456 0.77 PTGS2 (0.58) ALDH1A1TSHRPKMSMN1; SMN2GAA
SCHEMBL285616 0.76 GABRA5 (0.46) GABRA5
SCHEMBL3724318 0.75 PTGS1 (0.57) ALDH1A1L3MBTL1LMNAKMT2AHTT
SCHEMBL12543755 0.74 GABRA5 (0.54) ALDH1A1TSHRGABRA5KDM4ESMN1; SMN2
SCHEMBL30684510 0.74 GABRA5 (0.54) ALDH1A1TSHRGABRA5KDM4ESMN1; SMN2
SCHEMBL470207 0.73 GPBAR1 (0.48) ALDH1A1TSHRNPC1KDM4ERAB9A
SCHEMBL6096442 0.72 MAPK1 (0.43) ALDH1A1GABRA5NPC1KDM4ERAB9A
SCHEMBL300046 0.72 GABRA5 (0.52) ALDH1A1TSHRGABRA5NPC1KDM4E
SCHEMBL286093 0.72 GABRA5 (0.55) ALDH1A1TSHRGABRA5NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163728-B2 Pyrazoles HOFFMANN-LA ROCHE INC. (US) 2012-04-24 US disclosed
EP-2427455-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-03-14 EP disclosed
WO-2010127975-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO disclosed
US-20100286115-A1 PYRAZOLES ROCHE PALO ALTO LLC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286115-A1 PYRAZOLES GABRA5, GABRA1, GABRA3 ALDH1A1 724/4885TSHR 1785/4885GABRA5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.